Reports from University of Groningen Provide New Insights into Antineoplastic Monoclonal Antibodies (Clinical benefit of controversial first line systemic therapies for advanced stage ovarian cancer - ESMO-MCBS scores).
In: Women's Health Weekly, 2018-11-01, S. 281-281
serialPeriodical
Zugriff:
Titel: |
Reports from University of Groningen Provide New Insights into Antineoplastic Monoclonal Antibodies (Clinical benefit of controversial first line systemic therapies for advanced stage ovarian cancer - ESMO-MCBS scores).
|
---|---|
Zeitschrift: | Women's Health Weekly, 2018-11-01, S. 281-281 |
Veröffentlichung: | 2018 |
Medientyp: | serialPeriodical |
ISSN: | 1078-7240 (print) |
Sonstiges: |
|